PATENT CLAIM ANALYSIS

Application Number: 15941655
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "136100"]

Abstract:
Herein are provided bispecific anti-human A-beta/human transferrin receptor antibodies and methods of using the same.

Claim (Index 3):
The antibody according to  claim 1 , wherein\n a) the heavy chain that is fused to the additional Fab fragments has as C-terminal heavy chain amino acid residues the tripeptide LSP wherein the proline thereof is directly fused to the first amino acid residue of the additional Fab fragment or of the peptidic linker via a peptide bond, and b) the heavy chain that is not fused to the additional Fab fragments has as C-terminal heavy chain amino acid residues the tripeptide LSP, or SPG, or PGK.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14549102', '15847890', '15497782', '15284464', '15847448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7935299976043595
- 35 USC 102 Novelty (BERT): 0.5675177462439529
- Combined Prediction Score: 0.7709287724683188
- Mean Citation Score: 479.614112
- Max Citation Score: 494.60837
- Similarity Product: 318.41195653708337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test